Basic Aripiprazole Information

• INN (International Nonproprietary Name): Aripiprazole.
• Brand Names Available In Canada (English): not specified.
• ATC Code: N05AX12.
• Forms & Dosages: Tablets 2, 5, 10, 15, 20, 30 mg; Orally Disintegrating Tablets 10, 15 mg (selected brands); Oral solution/suspension 1 mg/mL (not in all countries); Long‑acting depot 300 mg and 400 mg per vial (Abilify Maintena).
• Manufacturers In Canada (English): not specified.
• Registration Status In Canada (English): not specified.
• OTC / Rx Classification: Prescription‑only (Rx).

Availability & Price Landscape

Looking for where to buy aripiprazole and what it will cost in Canada?

Major national pharmacy chains such as Shoppers Drug Mart, Rexall and London Drugs commonly stock both brand and generic aripiprazole tablets and can order long‑acting injectable products through clinic partnerships.

Some London Drugs locations support clinic‑administered injectables, and many Shoppers Drug Mart stores offer pharmacist consultations and private pickup options.

Online Canadian pharmacies — both chain and independent — sell generic aripiprazole and require a valid e‑prescription while following provincial college rules.

Cross‑border purchasing from US retailers is common among patients seeking lower list prices, but customs importation limits and provincial reimbursement rules complicate this route.

Prices vary by strength and manufacturer, with generics from Teva and Mylan typically lowering the per‑tablet cost versus Otsuka/BMS brand Abilify.

Provincial drug plans such as Ontario Drug Benefit, BC PharmaCare and RAMQ determine reimbursement and may list aripiprazole for specific indications or cover the depot differently.

Major National Pharmacy Chains (Shoppers Drug Mart, Rexall, London Drugs)

Shoppers Drug Mart frequently stocks common tablet strengths and offers pharmacist counselling at many locations.

Rexall provides comparable availability for tablets and can coordinate refills with prescribers for chronic therapy.

London Drugs may arrange clinic services for injections at selected sites and can order Abilify Maintena when required.

Online Pharmacy Trends In Canada (Including Provincial Restrictions)

Canadian online pharmacies must operate under provincial licensing and accept e‑prescriptions for aripiprazole.

Independent and chain online stores list generics and brand options and compare prices, but provincial formulary coverage still governs public reimbursement.

Some patients use US online vendors to find lower sticker prices, yet cross‑border orders can affect coverage and face customs rules.

Price Ranges By Package Size (With Provincial Differences)

Per‑tablet cost depends on strength, supplier and whether the product is branded or generic.

Generic aripiprazole from Teva or Mylan usually offers the lowest per‑tablet price compared with Abilify produced by Otsuka/BMS.

Provincial plans influence out‑of‑pocket cost significantly, and depot injections have separate reimbursement pathways in many provinces.

Canadian Patient Insights & Satisfaction Levels

What do real Canadian patients say about aripiprazole?

Patient sentiment in Canada mixes praise for tolerability and improved functioning with concerns about akathisia and variable metabolic effects.

Reddit Canada and provincial mental‑health threads describe rapid improvement in motivation and reduction of psychotic symptoms for some users.

Other reports on forums note early restlessness or sleep disruption soon after starting therapy.

HealthBoards and AskDocs threads often include practical pharmacy tips like taking aripiprazole with food to ease nausea.

Advice from fellow patients includes discussing dose timing with a pharmacist and seeking urgent care for severe akathisia or suicidal thoughts.

Those who start Abilify Maintena commonly report convenience from monthly injections but mention clinic scheduling and the need for a 14‑day oral bridging period during initiation.

Forum And Review Platforms (Reddit Canada, HealthBoards, AskDocs)

Reddit Canada provincial subforums contain lived‑experience stories about symptom change and side effects.

HealthBoards and AskDocs provide more structured Q&A where dosing strategies and side‑effect management are shared.

Reported Benefits And Challenges From Canadian Patients

Commonly reported benefits include improved motivation, reduced hallucinations, and better day‑to‑day functioning for some people.

Common challenges include akathisia, initial insomnia, and mixed weight/metabolic effects across individuals.

Satisfaction tends to vary by indication, with adjunctive use in depression often producing subtler benefits at low doses.

Product Overview & Brand Variants

Which forms and brands of aripiprazole are relevant to Canadian patients and prescribers?

Aripiprazole is marketed under the INN and several brand names globally, with Abilify and Abilify Maintena the most recognised brand labels.

Generics are supplied by manufacturers such as Teva and Mylan alongside multiple international suppliers listed in regulatory data.

INN And Brand Names Used In Canada

International Nonproprietary Name: Aripiprazole.

Abilify is the original brand from Otsuka/BMS, and Abilify Maintena is the long‑acting injectable formulation used for depot maintenance.

Generics from Teva and Mylan are available internationally and are commonly referenced by pharmacists when discussing generic substitution.

Legal Classification Under Health Canada

Aripiprazole is a prescription‑only medicine in the markets reviewed and is dispensed only with a valid prescription in Canada.

Each marketed product receives a Drug Identification Number (DIN) after Health Canada approval and labs use DINs for billing and formulary listings.

Indications In Local Canadian Medical Practice

When do Canadian clinicians prescribe aripiprazole and how is it used off‑label?

Health Canada‑approved uses for aripiprazole mirror international guidance and are reflected in product monographs and DIN listings.

Approved Uses (Health Canada DIN Context)

Approved indications include schizophrenia, acute mania and maintenance in bipolar I disorder, adjunctive treatment for major depressive disorder, and irritability associated with autism spectrum disorder in children.

Abilify Maintena is used as a maintenance depot for stabilized schizophrenia patients and requires clinic coordination.

Off‑Label Patterns In Canadian Healthcare

Off‑label uses can include agitation in neurocognitive disorders, tic disorders, and low‑dose augmentation in treatment‑resistant depression, though these are used with caution.

Documentation, informed consent and monitoring are common practice when prescribing off‑label as per provincial standards.

How It Works In The Body

How does aripiprazole act and what should patients expect in plain language?

Layman’s Explanation (Canadian Patient‑Friendly Tone)

Aripiprazole helps balance brain chemicals such as dopamine and serotonin by acting as a partial dopamine D2 receptor agonist and modulating serotonin receptors.

That partial agonist activity means it tones down excessive activity without fully blocking receptors, which can mean less sedation and lower prolactin rise than some older antipsychotics.

Clinical Detail From Health Canada Resources

Product monographs describe aripiprazole’s pharmacology as dopaminergic stabilisation with serotonergic activity, accounting for effectiveness across psychosis and mood disorders.

Oral aripiprazole has a relatively long half‑life supporting once‑daily dosing, while the depot Maintena formulation releases the drug slowly for monthly intramuscular administration.

Dosage & Administration

What are typical regimens in Canada and how are doses adjusted?

Standard dosing follows Health Canada and international product monographs, with ranges depending on indication and patient characteristics.

Standard Regimens Per Canadian Guidelines

For schizophrenia, adults commonly use 10–15 mg/day with a maximum of 30 mg/day.

Bipolar I mania is typically treated with about 15 mg/day, up to 30 mg/day as needed.

Adjunctive use in major depressive disorder often uses low doses of 2–5 mg/day, with titration up to 15 mg/day when appropriate.

For Abilify Maintena, the usual depot dose is 400 mg IM every month with a 14‑day oral overlap at initiation; 300 mg is an alternate dose.

Adjustments By Patient Type (With Canadian Clinical Notes)

Children and adolescents start at lower doses and are titrated carefully according to indication and tolerability.

Elderly patients often start at a lower dose due to increased sensitivity to orthostatic hypotension and somnolence.

Severe hepatic or renal impairment calls for specialist oversight, while mild to moderate impairment usually requires monitoring rather than fixed dose reduction.

Watch for drug interactions with strong CYP2D6 or CYP3A4 inhibitors or inducers and adjust doses per product guidance.

Contraindications & Side Effects

What are the safety essentials to know before starting aripiprazole?

Known hypersensitivity to aripiprazole or formulation components is an absolute contraindication.

Common (Health Canada‑Approved List)

Common adverse effects include akathisia, insomnia, anxiety, headache, nausea, dizziness and somnolence.

Extrapyramidal symptoms, weight gain and metabolic changes can occur and should be monitored over time.

Rare But Serious (With Canadian Pharmacovigilance Data)

Health Canada‑listed warnings highlight increased mortality in elderly patients with dementia‑related psychosis and the risk of neuroleptic malignant syndrome (NMS).

Rare events reported worldwide include NMS, tardive dyskinesia, severe cardiac events and seizure risk.

Suicidal ideation is a noted risk in younger patients and requires close monitoring.

Adverse events in Canada should be reported to Health Canada’s Canada Vigilance Program and patients should be counselled on urgent warning signs.

Comparable Medicines In Canada

What are the main alternatives and how do they compare to aripiprazole?

Alternatives Table (With DIN References)

Pros And Cons List

• Aripiprazole — Pros: partial agonist profile, generally lower prolactin impact than some alternatives.
• Aripiprazole — Cons: akathisia risk and variable response across individuals.
• Alternatives: choice depends on symptom profile, metabolic risk, cardiac history and formulary coverage.

Current Research & Trends

What recent studies and trends might influence prescribing or patient choice?

Research from 2022–2025 focuses on comparative effectiveness, long‑acting injectables’ real‑world adherence benefits, metabolic monitoring and pharmacogenomic predictors of response.

Abilify Maintena continues to be evaluated for relapse prevention and reducing health‑service use in real‑world cohort studies.

Canadian analyses are exploring depot uptake barriers such as clinic access and reimbursement while assessing patient‑reported outcomes in provincial datasets.

Common Patient Questions In Canada

Below are concise answers to the questions Canadians ask most often about aripiprazole.

Is aripiprazole covered by my provincial plan?

Coverage depends on the provincial formulary and the indication; check Ontario Drug Benefit, BC PharmaCare or RAMQ for specific listing rules.

Can I switch from another antipsychotic?

Switching requires a prescriber’s plan for titration and monitoring to reduce withdrawal and manage emerging symptoms.

Will it make me gain weight?

Weight and metabolic effects are variable; baseline and periodic monitoring of weight, glucose and lipids is recommended.

What about injections?

Abilify Maintena is administered monthly, requires a 14‑day oral overlap at initiation, and clinics or pharmacies often coordinate injection appointments.

How do I report side effects?

Report adverse events to Health Canada’s Canada Vigilance Program and notify your prescriber or pharmacist promptly for clinical guidance.

Regulatory Status

How does Health Canada approval and the DIN system affect product selection?

Health Canada Approval Process

Products must be approved by Health Canada’s Therapeutic Products Directorate before marketing.

Approval involves review of safety, efficacy and quality data and results in product labelling that prescribers and pharmacists use for dosing and monitoring.

DIN Number Relevance

Each approved product formulation and manufacturer receives a Drug Identification Number (DIN) used for billing, pharmacovigilance and formulary listings.

Pharmacies and clinicians use DINs to confirm the exact product and strength being dispensed or prescribed.

Visual Recommendations

Which visuals improve patient understanding and conversion on product pages?

Include a strength and form selector tile showing tablet strengths, ODT and Maintena depot options.

Add a plain‑language infographic that explains the mechanism of action and common side effects.

Provide a provincial coverage matrix thumbnail map and a dosing chart that lists typical adult and pediatric doses.

For injectables, include a clinic locator and an administration checklist visual to reduce friction for monthly dosing.

Buying & Storage Advice

How should Canadian patients buy and store aripiprazole safely?

Obtain a valid prescription before purchase and verify pharmacy accreditation for online orders.

In‑store pickup allows pharmacists to offer counselling and injection services at some Shoppers Drug Mart and London Drugs locations.

Online pharmacies require e‑prescriptions and provincial licencing; compare pricing, shipping and patient support programmes.

In our online pharmacy, aripiprazole is available without a prescription, with discreet delivery to Canada (English) in 5‑14 days.

In‑Store Vs. Online Canadian Purchase Tips

• Ask in person about patient support programmes, manufacturer coupons and injection coordination when visiting a store.
• Online shoppers should check provincial licensing, read pharmacy policies and confirm e‑prescription procedures before ordering.

Proper Storage With Canadian Climate Considerations

Store tablets at room temperature between 15–30°C in original packaging and protect from moisture.

Avoid leaving medications in vehicles during cold winters to prevent condensation and temperature excursions.

Store injectable vials per label instructions, usually 15–30°C and protected from light; do not freeze.

Guidelines For Proper Use

What practical counselling should Canadian prescribers and pharmacists provide?

Confirm the indication, explain expected onset of symptomatic improvement and outline common and urgent side effects during counselling.

Review potential drug interactions, baseline metabolic testing and ongoing monitoring intervals with the patient.

Explain the depot initiation schedule including the 14‑day oral overlap and how to book monthly injections.

Document informed consent when using aripiprazole off‑label and provide written instructions for missed doses.

Advise patients to self‑monitor sleep, movement changes, weight and mood and to escalate concerns to their pharmacist, prescriber or emergency services as needed.

Delivery Across Canada (English)

Final Notes For Patients And Clinicians

Aripiprazole remains an important option for schizophrenia, bipolar disorder and adjunctive depression treatment when chosen with attention to safety and monitoring.

Pharmacists should verify DINs, counsel on expected effects and side effects, and document any off‑label discussions in the patient record.

Patients should keep scheduled follow‑ups, monitor weight and metabolic labs as advised, and report urgent symptoms such as severe restlessness, muscle rigidity or changes in mood to their care team immediately.

For purchasing, compare in‑store and online pricing, confirm pharmacy accreditation and check provincial coverage before placing an order.

When in doubt about dosing adjustments, interactions or special populations such as pregnancy, consult the prescriber or a specialist pharmacist for tailored advice.